Growth hormone distribution kinetics are markedly reduced in adults with growth hormone deficiency

Clinical Endocrinology

Volumn 66, Issue 3, 2007, Pages 341-347

  Catalina, Pablo F ^a,b   Páramo, Concepción ^c   Andrade, Maria Amalia ^c   Mallo, Federico ^b  

^a HOSPITAL MONTECELO   (Spain)

^b UNIVERSITY OF VIGO   (Spain)

^c HOSPITAL XERAL CÍES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE; RECOMBINANT GROWTH HORMONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARTMENT MODEL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; KINETICS; MALE; MEAN RESIDENCE TIME; METABOLIC CLEARANCE RATE; METHODOLOGY; PRIORITY JOURNAL;

ADULT; AGED; CASE-CONTROL STUDIES; DRUG ADMINISTRATION SCHEDULE; GROWTH HORMONE-RELEASING HORMONE; HALF-LIFE; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; HUMANS; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; MODELS, BIOLOGICAL; MODELS, STATISTICAL; OCTREOTIDE; SOMATOSTATIN;

EID: 33846931092     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2006.02733.x     Document Type: Article

References (39)

1. Carroll, P.V., Christ, E.R., Bengtsson, B.A., Carlsson, L., Christiansen, J.S., Clemmons, D., Hintz, R., Ho, K., Laron, Z., Sizonenko, P., Sonksen, P.H., Tanaka, T. & Thorne, M. (1998) Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Journal of Clinical Endocrinology and Metabolism, 83, 382-395.
2. Bengtsson, B.A., Abstract, R., Bennmarker, H., Monson, J.P., Feldt-Rasmussen, U., Hernberg-Stahl, E., Westberg, B., Wilton, P. & Wuster, C. (1999) The effects of treatment and the individual responsiveness to GH replacement therapy in 665 GH-deficient adults. Journal of Clinical Endocrinology and Metabolism, 84, 3929-3935.
3. Weaver, J.U., Monson, J.P., Noonan, K., John, W.G., Edwards, A., Evans, K.A. & Cunningham, J. (1995) The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity and cardiovascular risk factors in hypopituitary adults. Journal of Clinical Endocrinology and Metabolism, 80, 153-159.
4. Le Roith, D., Bondy, C., Yakar, S., Liu, J.L. & Butler, A. (2001) The somatomedin hypothesis: 2001. Endocrine Reviews, 22, 53-74.
5. Boucher, B.J., Butterfield, W.J.H. & Whichelow, M.J. (1969) The disappearance of labelled human growth hormone from the forearm circulation in normal and diabetic subjects. Clinical Science, 37, 721-730.
6. Owens, D., Srivastava, M.C., Tompkins, C.V., Navarro, J.D.B. & Sönksen, P.H. (1973) Studies on the metabolic clearance rate, apparent distribution space and plasma half-disappearance time of unlabelled human growth hormone in normal subjects and in patients with liver disease, renal disease, thyroid disease and diabetes mellitus. European Journal of Clinical Investigations, 3, 284-294.
7. MacGillivray, M.H., Frohman, L.A. & Doe, J. (1970) Metabolic clearance and production rates of human growth hormone in subjects with normal and abnormal growth. Journal of Clinical Endocrinology, 30, 632-638.
8. Refetoff, S. & Sönksen, P.H. (1970) Disappearance rate of endogenous and exogenous human growth hormone in man. Journal of Clinical Endocrinology, 30, 386-392.
9. Cameron, D.P., Burger, H.G., Catt, K.J. & Doig, A. (1969) Metabolic clearance rate of radioiodinated human growth hormone in man. Journal of Clinical Investigation, 48, 1600-1608.
10. Taylor, A.L., Finster, J.L. & Mintz, D.H. (1969) Metabolic clearance and production rates of human growth hormone. Journal of Clinical Investigation, 48, 2349-2358.
11. Parker, M.L., Utiger, R.D. & Daughaday, W.H. (1962) Studies on human growth hormone. II. The physiological disposition and metabolic fate of human growth hormone in man. Journal of Clinical Investigation, 41, 262-268.
12. Marino, A.T., DiStefano, J.J. III & Landaw, E.M. (1992) DIMSUM: an expert system for multiexponential model discrimination. American Journal of Physiology, 262, E546-E556.
13. Marquart, D.W. (1963) An algorithm for least squares estimation of non-linear parameters. SIAM Journal, 11, 4314-4341.
14. DiStefano, J.J. III (1982) Noncompartmental vs. compartmental analysis: some bases for choice. American Journal of Physiology, 243, R1-R6.
15. Akaike, H. (1974) A new look at statistical model identification. IEEE Transactions on Automatic Control, 19, 716-723.
16. Akaike, H. (1978) A Bayesian analysis of the minimum AIC procedure. Annals of the Institute of Statistical Mathematics, 30A, 9-14.
17. Schwartz, G. (1978) Estimation of the dimension of a model. Annals of Statistics, 6, 461-464.
18. Matis, J.H., Wehrly, T.E. & Gerald, K.B. (1985) Use of residence time moments in compartmental analysis. American Journal of Physiology, 249, E409-E415.
19. Sohmiya, M. & Kato, Y. (1992) Renal clearance, metabolic clearance rate, and half-life of human growth hormone in young and aged subjects. Journal of Clinical Endocrinology and Metabolism, 75, 1487-1490.
20. Roelfsema, F., Biermasz, N.R. & Veldhuis, J.D. (2002) Pulsatile, nyctohemeral and entropic characteristis of GH secretion in adult GH-deficient patients: selectively decreased pulsatile release and increased secretory disorderliness with preservation of diurnal timing and gender distinctions. Clinical Endocrinology, 56, 79-87.
21. Dullaart, R.P.F., Meijer, S., Marbach, P. & Sluiter, W.J. (1992) Effect of somatostatin analogue, octreotide, on renal haemodynamics and albuminuria in acromegalic patients. European Journal of Clinical Investigation, 22, 494-502.
22. Berthold, H. & Del Pozo, E. (1989) Antidiuretic effect of sandostatin (SMS 201-995) in healthy volunteers. Acta Endocrinologica, 120, 708-714.
23. Baumann, G., Shaw, M.A. & Amburn, K. (1989) Regulation of plasma growth hormone binding proteins in health and disease. Metabolism, 38, 683-689.
24. Vahl, N., Moller, N., Lauritzen, T., Christiansen, J.S. & Jorgensen, J.O.L. (1997) Metabolic effects and pharmacokinetics of a growth hormone pulse in healthy adults: relation to age, sex, and body composition. Journal of Clinical Endocrinology and Metabolism, 82, 3612-3618.
25. Bright, G.M., Veldhuis, J.D., Iranmanesh, A., Baumann, G., Maheshwari, H. & Lima, J. (1999) Appraisal of growth hormone (GH) secretion: evaluation of a composite pharmacokinetic model that discriminates multiple components of GH input. Journal of Clinical Endocrinology and Metabolism, 84, 3301-3308.
26. Haffner, D., Schaefer, F., Girard, J., Ritz, E. & Mehls, O. (1994) Metabolic clearance of recombinant human growth hormone in health and chronic renal failure. Journal of Clinical Investigation, 93, 1163-1171.
27. Jorgensen, J.O., Flyvbjerg, A. & Christiansen, J.S. (1989) The metabolic clearance rate, serum half-time and apparent distribution space of authentic biosynthetic human growth hormone in growth hormone-deficient patients. Acta Endocrinologica, 120, 8-13.
28. García-Mayor, R.V.G., Pérez, A.J., Gándara, A., Andrade, A., Mallo, F. & Casanueva, F.F. (1993) Metabolic clearance rate of biosynthetic growth hormone after endogenous growth hormone suppression with a somatostatin analogue in chronic renal failure patients and control subjects. Clinical Endocrinology, 39, 337-343.
29. Catalina, P.F., Andrade, M.A., García-Mayor, R.V. & Mallo, F. (2002) Altered GH elimination kinetics in type 1 diabetes mellitus can explain the elevation in circulating levels: bicompartmental approach. Journal of Clinical Endocrinology and Metabolism, 87, 1785-1790.
30. Albertsson-Wikland, K., Rosberg, S., Libre, E., Lundberg, L.O. & Groth, T. (1989) Growth hormone secretory rates in children as estimated by deconvolution analysis of 24-h plasma concentration profiles. American Journal of Physiology, 257, E809-E814.
31. Hansen, R.K., Gravholt, C.H., Orskov, H., Rasmussen, M.H., Christiansen, J.S. & Jorgensen, J.O.L. (2002) Dose dependency of the pharmacokinetics and acute lipolytic actions of growth hormone. Journal of Clinical Endocrinology and Metabolism, 87, 4691-4698.
32. Anderson, D.H. (1983) Compartment Modeling and Tracer Kinetics. Springer-Verlag, Berlin.
33. Olson, D.R. & Matis, J.H. (1985) Residence time moments of stochastic compartmental model with age-dependent and time-dependent rates. Mathematical Computation and Biomedical Application, 1, 237-242.
34. Iranmanesh, A., Lizarralde, G. & Veldhuis, J.D. (1991) Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. Journal of Clinical Endocrinology and Metabolism, 73, 1081-1088.
35. Schaefer, F., Baumann, G., Haffner, D., Faunt, L.M., Johnson, M.L., Mercado, M., Ritz, E., Mehls, O. & Veldhuis, J.D. (1996) Multifactorial control of the elimination kinetics of unbound (free) growth hormone (GH) in the human: regulation by age, adiposity, renal function, and steady state concentrations of GH in plasma. Journal of Clinical Endocrinology and Metabolism, 81, 22-31.
36. Shah, N., Aloi, J., Evans, W.S. & Veldhuis, J.D. (1999) Time mode of Growth Hormone (GH) entry into the bloodstream and steady-state plasma gh concentrations, rather than sex, estradiol, or menstrual cycle stage, primarily determine the GH elimination rate in healthy young women and men. Journal of Clinical Endocrinology and Metabolism, 84, 2862-2869.
37. Davila, N., Alcañiz, J., Salto, L., Estrada, J., Barcelo, A. & Baumann, G. (1994) Serum growth hormone-binding protein is unchanged in adult panhypopituitarism. Journal of Clinical Endocrinology and Metabolism, 79, 1347-1350.
38. Mauras, N., Quarmby, V. & Bloedow, D.C. (1999) Pharmacokinetics of insulin-like growth factor I in hypopituitarism: correlation with binding proteins. American Journal of Physiology, 277, E579-E584.
39. Veldhuis, J.D., Bidlingmaier, M., Anderson, S.M., Evans, W.S., Wu, Z. & Strasburger, C.J. (2002) Impact of experimental blockade of peripheral growth hormone (GH) receptors on the kinetics of endogenous and exogenous GH removal in healthy women and men. Journal of Clinical Endocrinology and Metabolism, 87, 5737-5745.